182 related articles for article (PubMed ID: 33461040)
1. Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations.
Filosofov D; Kurakina E; Radchenko V
Nucl Med Biol; 2021; 94-95():1-19. PubMed ID: 33461040
[TBL] [Abstract][Full Text] [Related]
2. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.
Randhawa P; Olson AP; Chen S; Gower-Fry KL; Hoehr C; Engle JW; Ramogida CF; Radchenko V
Curr Radiopharm; 2021; 14(4):394-419. PubMed ID: 33430758
[TBL] [Abstract][Full Text] [Related]
3. Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with
Kostelnik TI; Olson AP; Grundmane A; Ellison PA; Mynerich J; Chen S; Marinova A; Randhawa P; Karaivanov D; Aluicio-Sarduy E; Barnhart TE; Orvig C; Ramogida CF; Hoehr C; Filosofov D; Engle JW; Radchenko V
Nucl Med Biol; 2023; 122-123():108352. PubMed ID: 37390607
[TBL] [Abstract][Full Text] [Related]
4. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
Ginj M; Hinni K; Tschumi S; Schulz S; Maecke HR
J Nucl Med; 2005 Dec; 46(12):2097-103. PubMed ID: 16330576
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic radionuclides: production and decay property considerations.
Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
[TBL] [Abstract][Full Text] [Related]
6. PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma.
Lee H; Riad A; Martorano P; Mansfield A; Samanta M; Batra V; Mach RH; Maris JM; Pryma DA; Makvandi M
J Nucl Med; 2020 Jun; 61(6):850-856. PubMed ID: 31676730
[TBL] [Abstract][Full Text] [Related]
7. Targeted radiotherapy using Auger electron emitters.
O'Donoghue JA; Wheldon TE
Phys Med Biol; 1996 Oct; 41(10):1973-92. PubMed ID: 8912375
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
[TBL] [Abstract][Full Text] [Related]
9. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
10. Auger electrons for cancer therapy - a review.
Ku A; Facca VJ; Cai Z; Reilly RM
EJNMMI Radiopharm Chem; 2019 Oct; 4(1):27. PubMed ID: 31659527
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
Aghevlian S; Boyle AJ; Reilly RM
Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
[TBL] [Abstract][Full Text] [Related]
12. Ultrasmall Gold Nanoparticles Radiolabeled with Iodine-125 as Potential New Radiopharmaceutical.
Wang R; Liu H; Antal B; Wolterbeek HT; Denkova AG
ACS Appl Bio Mater; 2024 Feb; 7(2):1240-1249. PubMed ID: 38323544
[TBL] [Abstract][Full Text] [Related]
13. Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies.
Karagiannis TC
Hell J Nucl Med; 2007; 10(3):155-9. PubMed ID: 18084655
[TBL] [Abstract][Full Text] [Related]
14. Auger: The future of precision medicine.
Pirovano G; Wilson TC; Reiner T
Nucl Med Biol; 2021; 96-97():50-53. PubMed ID: 33831745
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
16. Calculation of equivalent dose for Auger electron emitting radionuclides distributed in human organs.
Goddu SM; Howell RW; Rao DV
Acta Oncol; 1996; 35(7):909-16. PubMed ID: 9004771
[TBL] [Abstract][Full Text] [Related]
17. Radiobiological and dosimetric assessment of DNA-intercalated
Belchior A; Di Maria S; Fernandes C; Vaz P; Paulo A; Raposinho P
EJNMMI Res; 2020 Jul; 10(1):79. PubMed ID: 32661612
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6.
Humm JL; Howell RW; Rao DV
Med Phys; 1994 Dec; 21(12):1901-15. PubMed ID: 7700197
[TBL] [Abstract][Full Text] [Related]
19. Auger radiation targeted into DNA: a therapy perspective.
Buchegger F; Perillo-Adamer F; Dupertuis YM; Delaloye AB
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1352-63. PubMed ID: 16896663
[TBL] [Abstract][Full Text] [Related]
20. The assessment and management of risks associated with exposures to short-range Auger- and beta-emitting radionuclides. State of the art and proposals for lines of research.
Paquet F; Barbey P; Bardiès M; Biau A; Blanchardon E; Chetioui A; Lebaron-Jacobs L; Pasquier JL
J Radiol Prot; 2013 Mar; 33(1):R1-16. PubMed ID: 23296029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
